; Seaside Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Seaside Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 0 PAGES: 17

Seaside Therapeutics, LLC (Seaside) is a bio-pharmaceutical company, based in the US. The company discovers and develops drugs for the brain development disorders like mental retardation and autism. It develops drug candidates to correct and improve the course of Fragile X syndrome, autism, and other disorders of brain development. Seaside pipeline products include STX209, STX107 and STX110. Its product STX209 is a selective gamma-amino butyric acid type-B receptor agonist that inhibits glutamate signaling in the brain. The company collaborates with Vanderbilt University to develop next generation mGluR5 NAMs product candidate for the treatment of neurodevelopmental disorders. Seaside is headquartered in Cambridge, Massachusetts, the US.

More Info
  • pg 1
									                     Seaside Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals and
                                              Alliances Profile
       Reference Code: GDPH127283D                                                                                                          Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Seaside Therapeutics, LLC (Seaside) is a bio-pharmaceutical company, based in
                                                                                                              Seaside Therapeutics, LLC, Pharmaceuticals &
      the US. The company discovers and develops drugs for the brain development
                                                                                                              Healthcare, Key Facts
      disorders like mental retardation and autism. It develops drug candidates to correct
      and improve the course of Fragile X syndrome, autism, and other disorders of brain                       Web Address                        www.seasidetherapeutic
      development. Seaside pipeline products include STX209, STX107 and STX110. Its                                                               s.com
      product STX209 is a selective gamma-amino butyric acid type-B receptor agonist
                                                                                                               Revenue (US$ million)                            NA
      that inhibits glutamate signaling in the brain. The company collaborates with
      Vanderbilt University to develop next generation mGluR5 NAMs product candidate                           Number of Employees                              NA
      for the treatment of neurodevelopmental disorders.                                                       GlobalData

      Financial Deals Landscape
        Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deals                    Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013


                                                                                                                                 1      1                 1
                                                                                                          1

                                                                                           No. of Deals



                                                                                                                 0      0                         0                0
                                                                                                          0
                                                                                                               2007    2008     2009   2010      2011    2012   YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare,                         Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013


                         3                                                                                3
          No. of Deals




                                                                                           No. of Deals




                               3                                                                                        3               3
                         2                                                                                2
                                        1                                                                                                                 1
                         1                                                                                1
                                                 0         0         0
                         0                                                                                0
                             North    Europe    Asia-    Middle   South                                               Central         Genetic           Genito
                             Americ            Pacific    East     and                                                Nervous        Disorders          Urinary
                               a                          and     Central                                             System                          System And
                                                         Africa   Americ                                                                                  Sex
                                                                    a                                                                                  Hormones



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Seaside Therapeutics, LLC - Pharmaceuticals & Healthcare - Deals                                                                              Reference Code: GDPH127283D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ...................................................... 3
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ....................................................... 5
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013................................................... 6
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ........................................ 7
       Seaside Therapeutics, LLC, Medical Devices Deals, 2007 to YTD 2013 ........................................................................................... 8
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .................................................... 9
       Seaside Therapeutics, LLC, Pharmaceuticals & Healthcare, Deal Details ....................................................................................... 10
          Venture Financing......................................................................................................................................................................... 10
             Seaside Therapeutics Raises $30 Million In Venture Financing................................................................................................ 10
          Partnerships.................................................................................................................................................................................. 11
             Delsia Enters Into Co-Development Agreement With Seaside Therapeutics For Autism Spectrum Disorder Biomarkers ........ 11
             Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University ............................................................. 12
          Licensing Agreements .................................................................................................................................................................. 13
             Roche Enters Into Licensing Agreement With Seaside Therapeutics For mGluR5 Antagonists ............................................... 13
       Seaside Therapeutics, LLC - Key Competitors................................................................................................................................. 14
       Key Employees ................................................................................................................................................................................ 15
       Locations And Subsidiaries .............................................................................................................................................................. 16
          Head Office ................................................................................................................................................................................... 16
       Appendix ....................................................................................................................................................
								
To top